BioLife Solutions, Inc. (BLFS) Stock Analysis

BioLife Solutions, Inc. (BLFS) Stock Analysis — AI Research | MarketCI

BLFS

Market Closed

BioLife Solutions, Inc.

NASDAQHealthcare Medical - Instruments & Supplies

159 employees

CEO: Roderick de Greef

Founded: 1989

$26.60

+$0.00(+NaN%)

Market Cap

1.30B

Beta

1.97

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

BLFS Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for BLFS built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Hold

Pass %

57.14%

Score

4/7

Fair Value Estimate

Cash flow analysis • Multiple methods

-$4.56

AI Price Target

Machine learning • Price prediction

$28.10

Market Sentiment

News & social media analysis

0.00

Value Investor Price

Classic value analysis

$2.06

Financial Health

Bankruptcy risk assessment

26.56

Quality Score

Financial strength rating

4.00

AI Investment Grade

Deep analysis of filings & news

65.00

Key Investment Highlights

Important factors affecting BLFS investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

57.89% Good

Conditions Met

22.00/38.00

Due Diligence Score

57.89%

Due Diligence Conditions

Investment analysis conditions and results


	Pass
	Fail
	Fail
	Pass
	Pass
	Pass

Showing 1 to 6 of 46 conditions